Tony Matschulla

PhD Student

University of Freiburg
Institute of Experimental and Clinical Pharmacology and Toxicology

2022 PhD thesis, Albert-Ludwigs-University of Freiburg
2017 - 2022 PhD student in the lab of Prof. Dr. Lutz Hein, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg
2016 - 2017 Scientific Researcher in the lab of Prof. Dr. Robert Thimme / Dr. Maike Hofmann, Department of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, University Freiburg Medical Centre
2014 - 2016 Studies of Molecular Medicine (M.Sc.), University of Freiburg
2011 - 2014 Studies of Molecular Medicine (B.Sc.), Friedrich-Alexander-University Erlangen-Nürnberg
2008 - 2011 Training as Medical-Technical Assistant (MTA-L), Medical Training College (Medizinische Berufsfachschule) Dresden-Friedrichstadt

Awards, scholarships

2019 DGP-Poster Award at the Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) in Stuttgart: „DNA methyltransferase 1 is crucial for embryonic cardiac development”


  • El Khawanky N., Hughes A., Yu W., Myburgh R., Matschulla T., Taromi S., Aumann K., Clarson J., Vinnakota J.M., Shoumariyeh K., Miething C., Lopez A.F., Brown M.P., Duyster J., Hein L., Manz M.G., Hughes T.P., White D.L., Yong A.S.M. and Zeiser R. (2021) Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia. Nat Commun 12, 6436.
  • Matschulla T., Berry R., Gerke C., Doring M., Busch J., Paijo J., Kalinke U., Momburg F., Hengel H. and Halenius A. (2017) A highly conserved sequence of the viral TAP inhibitor ICP47 is required for freezing of the peptide transport cycle. Sci Rep 7, 2933.